Retinoid-dependent pathways suppress myocardial cell hypertrophy

Area of Science:

• Cardiovascular Biology
• Molecular Endocrinology
• Cellular Signaling

Background:

• Cardiac hypertrophy is a significant risk factor for heart failure.
• Alpha-adrenergic receptor agonists are known inducers of cardiac hypertrophy.
• Retinoid signaling pathways play crucial roles in cellular development and function.

Purpose of the Study:

• To investigate the role of retinoic acid (RA) in modulating cardiac muscle cell hypertrophy.
• To identify the specific signaling pathways involved in RA-mediated suppression of hypertrophy.
• To explore the potential therapeutic implications of RA signaling in cardiovascular disease.

Main Methods:

• Utilized an in vitro model of cardiac muscle cell hypertrophy.
• Administered phenylephrine (alpha-adrenergic agonist) and retinoic acid (RA).
• Performed transient transfection assays to analyze retinoic acid receptor (RAR/RXR) activity.

Main Results:

• Physiological concentrations of RA suppressed phenylephrine-induced increases in cell size and atrial natriuretic factor (ANF) gene expression.
• RA selectively inhibited alpha-adrenergic receptor-dependent hypertrophy, but not serum-induced hypertrophy.
• Data indicated that RAR/RXR heterodimers mediate the suppression of alpha-adrenergic receptor-dependent hypertrophy.

Conclusions:

• A retinoic acid (RA)-mediated pathway suppresses key features of cardiac hypertrophy induced by alpha-adrenergic stimulation.
• RAR/RXR heterodimers are crucial for this suppressive effect.
• These findings suggest a potential in vivo therapeutic pathway for managing cardiac hypertrophy.